Labs / Assays & in vitro testing
RudaCure
Incheon, South Korea · rudacure.com
RudaCure is a Korean drug discovery company focused on membrane proteins, including ion channels and GPCRs. It develops therapeutics for dry eye disease, chronic pain, psoriasis, and rare neurological disease, with offices in Incheon and Seoul, Korea.
They take quote requests by email.
What they offer
Pharmacology evaluation
Evaluates drug candidates in pharmacology studies for membrane-targeted programs.
In vivo assessment
Conducts in vivo studies as part of its CRO offering.
In vitro assessment
Conducts in vitro studies as part of its CRO offering.
Ion-channel screening
Screens candidates for ion-channel activity and selectivity.
Ocular-disease animal models
Uses ocular-disease animal models for preclinical evaluation.
What they work on
- Modalities
- ADC, Peptide, Viral vector, Cell therapy
- Species and models
- ocular-disease animal models, dry eye disease model, Sjögren's syndrome model
- Assays and studies
- electrophysiology, patch clamp, high-throughput electrophysiology, pharmacology evaluation, ion-channel screening, AI-based molecular prediction, structure-based design, molecular dynamics simulations
- Therapeutic areas
- dry eye disease, chronic pain, psoriasis, rare neurological disease, sensory disease, inflammatory disease, veterinary dry eye
- Type
- CRO
- Sites
- Incheon, Korea · Seoul, Korea
- Serves
- Korea, US, Japan, Europe
- Founded
- 2018
Similar labs. Genevoyager, ProtaGene, Sai Life, 3C Therapeutics
Found in a contract services directory. Listing built from rudacure.com. Work here? Claim this listing.